Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 160,982 shares at $34.66 ($5.5M) on 2021-08-13, disclosed to the SEC on 2021-08-17.
Open-market sale of $5.5M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.22 | 25,786 | $882K | 16.2% |
| 2 | $34.22 | 25,786 | $882K | 16.2% |
| 3 | $34.66 | 1,500 | $52K | 1.0% |
| 4 | $34.66 | 1,500 | $52K | 1.0% |
| 5 | $33.80 | 19,584 | $662K | 12.1% |
| 6 | $33.80 | 19,584 |
| $662K |
| 12.1% |
| 7 | $34.54 | 2,599 | $90K | 1.6% |
| 8 | $34.54 | 2,599 | $90K | 1.6% |
| 9 | $33.21 | 15,276 | $507K | 9.3% |
| 10 | $33.21 | 15,276 | $507K | 9.3% |
| 11 | $33.93 | 15,746 | $534K | 9.8% |
| 12 | $33.93 | 15,746 | $534K | 9.8% |
| Total | $33.89 avg | 160,982 | $5.5M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |